Skip to content

The effect of erythropoietin on acute spinal cord injury

Evaluating the effects of combination therapy with Erythropoietin and Methylprednisolone in patients with traumatic cervical spinal cord injury

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180923041103N1
Enrollment
54
Registered
2020-02-09
Start date
2015-12-19
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Cervical Spinal Cord Injury. Injury of nerves and spinal cord at neck level

Interventions

Intervention 1: Control group: methyl prednisolone (500 mg lyophilized vials, Ronak Daroo, Iran), 30 mg/kg IV infusion for the first hour followed by 5.4 mg/kg/h in the next 23 hours if referred withi
or if referred to the ED between the third and eighth hour after the trauma underwent treatment based on National Acute Spinal Cord Injury Study (NASCIS) III protocol for the following 47 hours. Inter

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with Acute Traumatic Cervical Spinal Cord Injury Admitted within 8 hours of injury Neurological lesion at C5 to C7 level Stable hemodynamics

Exclusion criteria

Exclusion criteria: Vascular Brain Disease Acute Myocardial Infarction Thrombotic Diseases Cardiac Arrhythmia Heart Failure Peripheral Vascular Disorders Polycythemia Porphyria Malignancy Neurological Disorders Known Psychiatric Disorders Acute or Chronic Kidney Disease Acute Spinal Cord Injury caused by weapons Pregnancy Lactation Allergy to Erythropoietin or Human Albumin

Design outcomes

Primary

MeasureTime frame
American Spinal Injury Association (ASIA) score. Timepoint: Baseline, 6 and 12 months after intervention. Method of measurement: Medical History and Physical Examination.;Sphincter Function. Timepoint: Baseline, 6 and 12 months after intervention. Method of measurement: Physical Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Bahadoorkhan

Mashhad University of Medical Sciences

bahadorkhangh@mums.ac.ir+98 51 3840 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026